Fiona Scott Morton

Fiona Scott Morton's AcademicInfluence.com Rankings

Fiona Scott Morton

Economics

#1425

World Rank

#1646

Historical Rank

#636

USA Rank

economics Degrees

Download Badge

Economics

Why Is Fiona Scott Morton Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Fiona M. Scott Morton is an American economist who serves as the Theodore Nierenberg Professor at Yale School of Management. Her research in industrial organization has covered industries including magazines, shipping, pharmaceuticals, and internet retail. She served as associate dean of the Yale School of Management from 2007 to 2010.

(See a Problem?)

Fiona Scott Morton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Internet Car Retailing (2000) (378)
The Strategic Positioning of Store Brands in Retailer–Manufacturer Negotiations (2004) (299)
Hospitals, market share, and consolidation. (2013) (264)
Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000) (228)
The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2008) (200)
How the Internet Lowers Prices: Evidence from Matched Survey and Automobile Transaction Data (2006) (191)
The Impact of Consumer Inattention on Insurer Pricing in the Medicare Part D Program (2015) (168)
Love or Money? The Effects of Owner Motivation in the California Wine Industry (1998) (165)
Market Size and Pharmaceutical Innovation (2011) (158)
A Proposal to Limit the Anti-Competitive Power of Institutional Investors (2017) (149)
Consumer Information and Discrimination: Does the Internet Affect the Pricing of New Cars to Women and Minorities? (2003) (144)
The Distortionary Effects of Government Procurement: Evidence from Medicaid Prescription Drug Purchasing (2004) (142)
Do Increasing Markups Matter? Lessons from Empirical Industrial Organization (2019) (115)
The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules (1997) (114)
Behavioral Biases Meet the Market: The Case of Magazine Subscription Prices (2005) (90)
Providing prescription drug coverage to the elderly: America's experiment with Medicare Part D. (2008) (84)
What matters in a price negotiation: Evidence from the U.S. auto retailing industry (2011) (58)
Out-of-Network Emergency-Physician Bills - An Unwelcome Surprise. (2016) (54)
The Strategic Positioning of Store Brands in Retailer - Manufacturer Bargaining (2000) (53)
Antitrust and Innovation: Welcoming and Protecting Disruption (2019) (50)
Surprise! Out-of-Network Billing for Emergency Care in the United States (2017) (47)
Strategic Patent Acquisitions (2013) (44)
The Medium-Term Impact of Medicare Part D on Pharmaceutical Prices (2011) (41)
Markets: State Franchise Laws, Dealer Terminations, and the Auto Crisis (2010) (41)
The Impact of the Entry of Biosimilars: Evidence from Europe (2016) (38)
Out-Of-Network Billing And Negotiated Payments For Hospital-Based Physicians. (2019) (38)
Patent Assertions: Are We Any Closer to Aligning Reward to Contribution? (2015) (37)
Consumer Benefit from Use of the Internet (2006) (36)
Data Impediments to Empirical Work on Health Insurance Markets (2011) (31)
Standard Setting Organizations Can Help Solve the Standard Essential Patents Licensing Problem (2013) (23)
Horizontal Integration Between Brand and Generic Firms in the Pharmaceutical Industry (2002) (22)
The Interaction between a Most-Favored-Customer Clause and Price Dispersion: An Empirical Examination of the Medicaid Rebate Rules of 1990 (1997) (21)
Scarcity Rents in Car Retailing: Evidence from Inventory Fluctuations at Dealerships (2006) (21)
State Casket Sales Restrictions: A Pointless Undertaking? (2008) (21)
Antitrust Enforcement Against Platform MFNs (2017) (21)
Markets for Pharmaceutical Products11The authors thank Tom McGuire for editorial advice and improvements and participants at the Handbook conference for helpful suggestions (2011) (20)
Are Health Care Services Shoppable? Evidence from the Consumption of Lower-Limb MRI Scans (2018) (20)
Testing the Theory of Common Stock Ownership (2020) (20)
Framing the Chicago School of Antitrust Analysis (2020) (19)
Horizontal Shareholding and Antitrust Policy (2018) (18)
Five Principles for Vertical Merger Enforcement Policy (2019) (15)
Inventory Fluctuations and Price Discrimination: The Determinants of Price Variation in Car Retailing (2005) (13)
A Test of Bargaining Theory in the Auto Retailing Industry ∗ (2004) (12)
Evaluating the Evidence on Vertical Mergers (2020) (11)
INTEROPERABILITY AS A COMPETITION REMEDY FOR DIGITAL NETWORKS (2021) (11)
Entry Decisions in the Generic Pharmaceutical Industry (1997) (10)
Joint Response to the House Judiciary Committee on the State of Antitrust Law and Implications for Protecting Competition in Digital Markets (2020) (9)
Physician agency, consumerism, and the consumption of lower-limb MRI scans. (2021) (9)
A Model of Generic Drug Shortages : Supply Disruptions , Demand Substitution , and Price Control (2015) (7)
International Coherence in Digital Platform Regulation: An Economic Perspective on the US and EU Proposals (2021) (6)
Research into biomarkers: how does drug procurement affect the design of clinical trials? (2013) (5)
Addictive Technology and Its Implications for Antitrust Enforcement (2021) (5)
The Impact of the Entry of Biosimilars: Evidence from Europe (2018) (5)
Evaluating Innovation in the Pharmaceutical Industry (2004) (5)
Fairness and Contestability in the Digital Markets Act (2021) (4)
Unlocking Antitrust Enforcement (2018) (4)
The Objectives of the Fda's Office of Generic Drugs (1997) (4)
The Year in Review: Economics at the Antitrust Division: 2011 (2012) (4)
The 2010 HMGs Ten Years Later: Where Do We Go From Here? (2021) (3)
Platform Annexation (2021) (3)
The Year in Review: Economics at the Antitrust Division: 2011 (2012) (3)
A Unifying Analytical Framework for Loyalty Rebates (2016) (3)
Recommendations and Comments on the Draft Vertical Merger Guidelines (2020) (3)
The Effect of Information and Institutions on Price Negotiations : Evidence from Matched Survey and Auto Transaction Data ∗ (2003) (3)
Consumer Protection for Online Markets and Large Digital Platforms (2021) (3)
Roadmap for a Monopolization Case Against Google Regarding the Search Market (2020) (2)
Equitable Interoperability: The 'Super Tool' of Digital Platform Governance (2021) (2)
The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules (1996) (1)
State Casket Sales and Restrictions: A Pointless Undertaking? (2006) (1)
1% Steps for Health Care Reform: Implications for health care policy and for researchers. (2021) (1)
Introduction to RIO Symposium Issue on Store Brands (2004) (1)
Pay-for-Delay (2013) (1)
Enforcing the Digital Markets Act: Institutional Choices, Compliance, and Antitrust (2023) (1)
TWELVE Markets for Pharmaceutical Products 1 (2011) (1)
Bias and Loss Aversion in the Market for Autos November 2006 PRELIMINARY (2006) (0)
Penn Law: Legal Scholarship Repository Penn Law: Legal Scholarship Repository Horizontal Shareholding and Antitrust Policy Horizontal Shareholding and Antitrust Policy (2020) (0)
The Problems of Price Controls: History Shows that These Policies Lead to Shortages and Stagnation; so Why Do We Want to Control Prescription Drug Prices? (2001) (0)
Where Do We Go From Here: Open Questions and Policy Considerations (2014) (0)
EU ETS: First Phase (2009) (0)
Out-of-Network Emergency-Physician Bills. (2017) (0)
Preserving the Royalty-Free Standards Ecosystem (2022) (0)
Provider Consolidation: What’s Different Today? (2016) (0)
We Can’t Spend All Our Money on Health Care (2018) (0)
Firm pricing and entry (1994) (0)
The 2010 HMGs Ten Years Later: Where Do We Go From Here? (2021) (0)
Innovation incentives in a pandemic (2020) (0)
More Competitive Search Through Regulation (2021) (0)
The Objectives of the Fda&Apos;S Office of Generic Drugs (1997) (0)
Entry and Predation: British Shipping Cartels 1879-1929 (1996) (0)
Turning Physician Leaders into Business Managers (2016) (0)
Evaluating the Evidence on Vertical Mergers-February 26, 2020 (2020) (0)

This paper list is powered by the following services:

Other Resources About Fiona Scott Morton

en.wikipedia.org

What Schools Are Affiliated With Fiona Scott Morton?

Fiona Scott Morton is affiliated with the following schools: